# Bosentan and Pulmonary Endothelial Function

> **NCT01721564** · NA · COMPLETED · sponsor: **Prof David S Celermajer** · enrollment: 8 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** Bosentan

## Key facts

- **NCT ID:** NCT01721564
- **Lead sponsor:** Prof David S Celermajer
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04
- **Primary completion:** 2009-05
- **Final completion:** 2009-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01721564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01721564, "Bosentan and Pulmonary Endothelial Function". Retrieved via AI Analytics 2026-09-26 from https://api.ai-analytics.org/clinical/NCT01721564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*